Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker's best-selling opioid addiction drug Suboxone fared better than expected in the face of competition from copycats.
from Reuters: Health News https://ift.tt/33xxVoO
via
IFTTT
0 comments:
Post a Comment